Rhode Island officials began a new review of the merger after a previous application lapsed in October, because of difference between the state and the applicants.
Officials from Lifespan said in the report that the regulators had sent a list of questions of deficiencies to the system, which has until Dec. 11 to respond.
Under the proposed merger, Lifespan would control 70 percent of the hospitals in Rhode Island, which would include seven hospitals in total with the acquisition of Care New England’s three facilities.
Read the Beacon’s report about the ongoing review of the Lifespan/Care New England merger.